Skip to main content
Top
Literature
1.
go back to reference Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Eur Heart J. 2019:ehz486. https://doi.org/10.1093/eurheartj/ehz486. Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Eur Heart J. 2019:ehz486. https://​doi.​org/​10.​1093/​eurheartj/​ehz486.
2.
go back to reference Eurich DT, McAlister FA. Wrongfully accused: metformin use in heart failure. Expert Rev Cardiovasc Ther. 2011 Feb;9(2):147–50.CrossRef Eurich DT, McAlister FA. Wrongfully accused: metformin use in heart failure. Expert Rev Cardiovasc Ther. 2011 Feb;9(2):147–50.CrossRef
3.
go back to reference Aguilar D, Chan W, Bozkurt B, Ramasubbu K, Deswal A. Metformin use and mortality in ambulatory patients with diabetes and heart failure. Circ Heart Fail. 2011 Jan;4(1):53–8.CrossRef Aguilar D, Chan W, Bozkurt B, Ramasubbu K, Deswal A. Metformin use and mortality in ambulatory patients with diabetes and heart failure. Circ Heart Fail. 2011 Jan;4(1):53–8.CrossRef
5.
go back to reference Chawla R, Madhu SV, Makkar BM, Ghosh S, Saboo B, Kalra S. RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020. IJEM. 2020;24(1):1–122.PubMed Chawla R, Madhu SV, Makkar BM, Ghosh S, Saboo B, Kalra S. RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020. IJEM. 2020;24(1):1–122.PubMed
Metadata
Title
SGLT2 inhibitor/GLP-1 receptor agonists as first step monotherapy—evidence and implications
Authors
Anil Pareek
Ravi T. Mehta
Shruti Dharmadhikari
Publication date
01-10-2020
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 4/2020
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-020-00833-4

Other articles of this Issue 4/2020

International Journal of Diabetes in Developing Countries 4/2020 Go to the issue